BDBM329899 (s.e.)-((1R,2R,3S,4R)-4-(2-(4-(dimethylamino)naphthalen-1-yl)pyrazolo[1,5-::US10202389, Compound I-107::US9663525, Compound I-107
SMILES: CN(C)c1ccc(-c2cc3nccc(N[C@@H]4C[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]4O)n3n2)c2ccccc12
InChI Key: InChIKey=DWYLUBMPXHUNEX-FSICJWCISA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ubiquitin-like modifier-activating enzyme 1 (Homo sapiens (Human)) | BDBM329899 ((s.e.)-((1R,2R,3S,4R)-4-(2-(4-(dimethylamino)napht...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc. US Patent | Assay Description The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi... | US Patent US10202389 (2019) BindingDB Entry DOI: 10.7270/Q2DN475J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E2 ubiquitin-conjugating enzyme E1 (Homo sapiens (Human)) | BDBM329899 ((s.e.)-((1R,2R,3S,4R)-4-(2-(4-(dimethylamino)napht...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc. US Patent | Assay Description The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi... | US Patent US9663525 (2017) BindingDB Entry DOI: 10.7270/Q2HM5BJP | |||||||||||
More data for this Ligand-Target Pair |